Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200 Day Moving Average – Time to Sell?

Shares of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.94 and traded as high as $6.05. Cumberland Pharmaceuticals shares last traded at $5.31, with a volume of 168,177 shares traded.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on Cumberland Pharmaceuticals in a report on Friday, February 14th. They set a “hold” rating on the stock.

Cumberland Pharmaceuticals Price Performance

The stock has a market cap of $74.55 million, a P/E ratio of -6.90 and a beta of 0.12. The company has a current ratio of 1.13, a quick ratio of 0.99 and a debt-to-equity ratio of 0.41. The company’s fifty day simple moving average is $3.11 and its 200-day simple moving average is $1.94.

Institutional Trading of Cumberland Pharmaceuticals

A hedge fund recently raised its stake in Cumberland Pharmaceuticals stock. Two Sigma Investments LP boosted its holdings in shares of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) by 94.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 37,649 shares of the specialty pharmaceutical company’s stock after purchasing an additional 18,271 shares during the period. Two Sigma Investments LP owned about 0.27% of Cumberland Pharmaceuticals worth $89,000 as of its most recent SEC filing. 15.51% of the stock is owned by institutional investors.

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.